Impact of ACEI/ARB use on COVID-19 mortality in patients with ischaemic heart disease: insights from South Korean National health insurance service data

Background The COVID-19 pandemic has highlighted the importance of understanding the complex interactions between pre-existing conditions, such as ischaemic heart disease (IHD), and mortality risk. This study aims to investigate the associations among COVID-19 mortality, the presence of IHD, and the...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	BMC infectious diseases Ročník 25; číslo 1; s. 1529 - 12
Hlavní autori:	Kim, Shin-Woo, Goo, Taewan, Noh, Seunghwan, Lee, Seungyeoun, Oh, Bumjo, Park, Taesung
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	London BioMed Central 10.11.2025 BioMed Central Ltd BMC
Predmet:	Adult Aged Aged, 80 and over Angiotensin II receptor blockers Angiotensin Receptor Antagonists - therapeutic use Angiotensin receptor blockers Angiotensin-Converting enzyme inhibitors Angiotensin-Converting Enzyme Inhibitors - therapeutic use Cardiac patients Care and treatment Comorbidity COVID-19 - complications COVID-19 - mortality Diagnosis Dosage and administration Enzyme inhibitors Female Humans Infectious Diseases Internal Medicine Ischaemic heart disease Male Medical Microbiology Medicine Medicine & Public Health Middle Aged Myocardial Ischemia - complications Myocardial Ischemia - drug therapy Myocardial Ischemia - epidemiology Myocardial Ischemia - mortality National health insurance data National Health Programs Parasitology Republic of Korea - epidemiology Retrospective Studies SARS-CoV-2 Tropical Medicine Republic of Korea South Korea COVID-19 mortality National health insurance data Angiotensin-Converting enzyme inhibitors Ischaemic heart disease Angiotensin receptor blockers
ISSN:	1471-2334, 1471-2334
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!